![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | YBEY | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Ybey (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of YBEY mRNA] | CTD | PMID:22206623 | YBEY | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Ybey (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of YBEY mRNA | CTD | PMID:22206623 | YBEY | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of YBEY mRNA | CTD | PMID:23019147 | YBEY | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of YBEY mRNA | CTD | PMID:30851411 | YBEY | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Ybey (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of YBEY mRNA | CTD | PMID:36041667 | YBEY | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of YBEY mRNA | CTD | PMID:33167477 | YBEY | Human | alpha-Zearalanol | multiple interactions | ISO | Ybey (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of YBEY mRNA | CTD | PMID:35163327 | YBEY | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of YBEY mRNA | CTD | PMID:24449571 | YBEY | Human | benzo[a]pyrene | increases methylation | ISO | Ybey (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of YBEY promoter | CTD | PMID:27901495 | YBEY | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of YBEY mRNA | CTD | PMID:38218311 | YBEY | Human | bisphenol A | decreases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of YBEY mRNA | CTD | PMID:25181051 | YBEY | Human | bisphenol A | multiple interactions | ISO | Ybey (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of YBEY mRNA | CTD | PMID:36041667 | YBEY | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of YBEY protein | CTD | PMID:33376534 | YBEY | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [ginger extract results in increased abundance of Oils and Volatile] inhibits the reaction [bisphenol A results in increased expression of YBEY protein] | CTD | PMID:33376534 | YBEY | Human | bisphenol A | increases methylation | ISO | Ybey (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of YBEY gene | CTD | PMID:28505145 | YBEY | Human | bisphenol F | multiple interactions | ISO | Ybey (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of YBEY mRNA | CTD | PMID:36041667 | YBEY | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of YBEY mRNA | CTD | PMID:35301059 | YBEY | Human | cadmium dichloride | decreases methylation | ISO | Ybey (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of YBEY promoter | CTD | PMID:22457795 | YBEY | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of YBEY mRNA | CTD | PMID:35301059 | YBEY | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of YBEY mRNA | CTD | PMID:25979313 | YBEY | Human | chlorpyrifos | decreases expression | ISO | Ybey (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of YBEY mRNA | CTD | PMID:37019170 | YBEY | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | YBEY | Human | flutamide | increases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of YBEY mRNA | CTD | PMID:24793618 | YBEY | Human | folic acid | multiple interactions | ISO | Ybey (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of YBEY mRNA] | CTD | PMID:22206623 | YBEY | Human | gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of YBEY mRNA | CTD | PMID:34408198 | YBEY | Human | gentamycin | decreases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of YBEY mRNA | CTD | PMID:33387578 | YBEY | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of YBEY mRNA | CTD | PMID:26272509 | YBEY | Human | methylmercury chloride | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YBEY mRNA | CTD | PMID:27188386 | YBEY | Human | N-ethyl-N-nitrosourea | increases mutagenesis | ISO | Ybey (Mus musculus) | 6480464 | Ethylnitrosourea results in increased mutagenesis of YBEY intron | CTD | PMID:27776689 | YBEY | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of YBEY mRNA | CTD | PMID:28801915 | YBEY | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of YBEY mRNA | CTD | PMID:21420995 | YBEY | Human | perfluorooctanoic acid | multiple interactions | ISO | Ybey (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of YBEY mRNA | CTD | PMID:35163327 | YBEY | Human | pirinixic acid | increases expression | ISO | Ybey (Mus musculus) | 6480464 | pirinixic acid results in increased expression of YBEY mRNA | CTD | PMID:23811191 | YBEY | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of YBEY mRNA | CTD | PMID:30851411 | YBEY | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | YBEY | Human | sodium arsenite | decreases expression | ISO | Ybey (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of YBEY mRNA | CTD | PMID:36209798 | YBEY | Human | Soman | decreases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | Soman results in decreased expression of YBEY mRNA | CTD | PMID:19281266 | YBEY | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of YBEY mRNA | CTD | PMID:31533062 | YBEY | Human | thioacetamide | decreases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of YBEY mRNA | CTD | PMID:34492290 | YBEY | Human | trichloroethene | decreases expression | ISO | Ybey (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of YBEY mRNA | CTD | PMID:33387578 | YBEY | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of YBEY mRNA | CTD | PMID:25979313 | YBEY | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of YBEY mRNA | CTD | PMID:23179753 more ... | YBEY | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of YBEY mRNA | CTD | PMID:27188386 | |